2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 6
As coordinator: 1
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0.2*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 0 | 39.969.692 | 3.435.688 | 2 | ||
2020 | 0 | 27.887.638 | 1.100.000 | 1 | ||
2019 | 2.986.749 | 9.793.660 | 1.506.602 | 1 | 2 |
Total number of partners: 108
Partner loyalty:
Frequent Partner: (> 2 projects): 15
Rare Partner: 93
Frequent / Rare Partner Ratio: 0.16
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-04-01 | Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance in a sustainable global platform | NeoIPC | participant | 9.999.817 | 13 |
2021-03-01 | European Clinical Research Alliance on Infectious Diseases | ECRAID-Base | participant | 29.969.875 | 20 |
2020-12-01 | Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA | ORCHESTRA | participant | 27.887.638 | 33 |
2019-04-01 | The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use | VALUE-Dx | participant | 6.799.100 | 26 |
2019-01-01 | REACH: Russian European Alliance for research among women, Children and adolescents impacted by HIV, TB and HCV | REACH | coordinator | 2.986.749 | 9 |
2019-01-01 | European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan | ECRAID-Plan | participant | 2.994.560 | 13 |